[Study of the efficacy of neuramide in the treatment of pain in cancer patients].
The effectiveness of neuramide as an analgesic was assessed in 71 patients with neuritic pain in an oncological radiotherapy ward. 1-2 vials i.m. twice a day for results in 54%, poor results in 13%, and nil results in 21%. The degree of analgesia was that the drug is useful as an analgesic, anti-inflammatory, cell membrane stabilising, and neurotrophic preparation in certain well-defined pain syndromes, especially those of a secondary nature. Attention is also drawn to its excellent tolerance and the complete absence of side-effects.
D000698:Analgesia / Q000379:methods*; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D004341:Drug Evaluation; D006801:Humans; D007273:Injections, Intramuscular; D009369:Neoplasms / Q000150:complications*
D000894:Anti-Inflammatory Agents, Non-Steroidal
Studio dell'efficacia della neuramide nel trattamento del dolore su pazienti neoplastici.